Infection-Related Malignant Neoplasm — Trials

Infection-Related Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

539 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 133
Recruiting: 71
Ph III recruiting: 2
Growth YoY: −24%
Industry share: 17%
Top sponsor: National Cancer Institute (NCI)
Termination share: 30.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (75)

clinicaltrialsPublishedShowing 251–261 of 261 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00002189	Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals	completed	Phase 2	—	Baker Norton PharmaceuticalsINDUSTRY	1	Jun 24, 2005	clinicaltrials
NCT00002212	A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma	completed	Phase 2	27	Ligand PharmaceuticalsINDUSTRY	1	Jun 24, 2005	clinicaltrials